Related Experiment Videos

Obesity is associated with higher mortality in patients with cardiogenic shock

Paari Dominic Swaminathan, Monica Stancu, Prasannakumar Venkatesh

    International Journal of Cardiology
    |August 8, 2006
    PubMed

    Insights

    Obese patients experiencing cardiogenic shock after acute myocardial infarction face a higher mortality risk. This highlights the need to consider obesity when assessing outcomes in these critical patients.

    Area of Science:

    • Cardiology
    • Obesity Medicine

    Background:

    • Acute myocardial infarction (AMI) is a significant cause of mortality.
    • Cardiogenic shock (CS) following AMI carries a high risk of death.
    • Predictors of mortality in CS patients are well-studied, but obesity's impact remains under-evaluated.

    Discussion:

    • This study investigated mortality predictors in cardiogenic shock patients, specifically examining the role of obesity.
    • A cohort of sixty-one patients with cardiogenic shock was analyzed.
    • Obesity was identified as a significant factor associated with increased mortality risk.

    Key Insights:

    • Obese patients with cardiogenic shock exhibit a higher mortality risk compared to their non-obese counterparts.
    • Obesity is a critical, previously under-assessed, predictor of adverse outcomes in cardiogenic shock.
    • Findings underscore the importance of incorporating obesity status into risk stratification models for AMI patients with CS.

    Outlook:

    • Further research is warranted to elucidate the mechanisms underlying increased mortality in obese CS patients.
    • Clinical guidelines may need to be updated to address obesity as a risk factor in cardiogenic shock management.
    • Future studies should explore targeted interventions for obese patients to improve cardiogenic shock outcomes.

    Related Concept Videos

    Obesity01:24

    Obesity

    The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
    Drug Dosing: Obese Patients01:21

    Drug Dosing: Obese Patients

    In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

    Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

    Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
    Blood Pressure Imbalances and Circulatory Shock01:24

    Blood Pressure Imbalances and Circulatory Shock

    Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
    Blood Pressure: Hypertension and Hypotension
    Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...